Pre-transplant coronary artery disease increases all-cause mortality and post-transplant cardiovascular events in kidney recipients
Pre-existing heart disease increases risks for kidney transplant patients
This meta-analysis of 112,416 kidney transplant recipients found that pre-existing coronary artery disease (CAD) is associated with signific…
Patients with pre-existing coronary artery disease face significantly higher risks of death and graft failure after receiving a kidney trans…
SGLT2 inhibitors provide robust prognostic benefits in heart failure with inconsistent results in post-myocardial infarction settings
SGLT2 inhibitors show promise for heart failure and diabetes
This narrative review examines the cardiovascular and metabolic effects of SGLT2 inhibitors, specifically empagliflozin and dapagliflozin. T…
New evidence shows how SGLT2 inhibitors may protect the heart and manage risks for patients with type 2 diabetes and heart failure.
Upadacitinib Treatment for Concurrent Atopic Dermatitis Vitiligo and Alopecia Areata
One drug improved skin, hair, and pigment in one man
A 57-year-old man with severe, refractory skin conditions showed significant improvement in dermatitis, vitiligo, and hair loss on upadaciti…
A single patient with three skin conditions saw dramatic improvement after taking upadacitinib for one year.
High sFlt-1 levels correlate with increased PPCM risk in postpartum women
High sFlt-1 Levels Linked to Risk of Heart Failure
This meta-analysis evaluates the association between circulating sFlt-1 and peripartum cardiomyopathy (PPCM) risk. Findings indicate that hi…
New data shows a link between high sFlt-1 levels and heart muscle damage in women after giving birth, especially those with pre-eclampsia.
Bedtime antihypertensive dosing shows no cardiovascular benefit over morning dosing
Bedtime vs. Morning Blood Pressure Meds: No Clear Winner
A meta-analysis of randomized trials compared bedtime versus morning administration of antihypertensives. No evidence of a difference in maj…
Taking blood pressure medication at bedtime did not reduce heart attacks, strokes, or deaths more than morning dosing in a large analysis of…
Incidental arrhythmia findings on ambulatory ECG vary widely in adults without prior atrial fibrillation
Hidden heart rhythm problems found in up to 96% of adults
This systematic review and meta-analysis of 136,344 community-based adults without prior atrial fibrillation found that the prevalence of in…
A review of 136,344 adults found hidden heart rhythm issues in up to 96% of people without known atrial fibrillation.
Network meta-analysis reveals resistance training offers largest LVEF gains for adult heart failure patients compared to other exercise types
Resistance training shows greatest heart function boost in network analysis
A network meta-analysis of 3,519 adult heart failure patients found resistance training yielded the greatest improvement in left ventricular…
A network meta-analysis of 3,519 heart failure patients found resistance training improved heart function more than other exercise types, wi…
Microcirculatory dysfunction during cardiac surgery remains heterogeneous and inconclusive in current clinical evidence
Microcirculation in Cardiac Surgery: What We Know and What Remains Unclear
This narrative review examines microcirculatory dysfunction in patients undergoing cardiac surgery with cardiopulmonary bypass. The authors …
A review of cardiac surgery research shows mixed results on microcirculation, with many gaps between lab findings and patient care.
Conduction system pacing improves LVEF and reduces HF hospitalization vs biventricular pacing in heart failure
Conduction system pacing shows promise for heart failure patients
This systematic review and meta-analysis of 7,019 adult HF patients (LVEF ≤ 50%) found that conduction system pacing (CSP) was associated wi…
A meta-analysis of 7,019 heart failure patients suggests conduction system pacing may improve heart function and reduce hospitalizations com…
FDA Approves Furosemide for Edema and Hypertension
FDA approves furosemide to treat fluid buildup and high blood pressure.
The FDA approved furosemide for edema associated with congestive heart failure, cirrhosis, and renal disease, and for hypertension in adults…
The FDA has approved furosemide, a diuretic (water pill), to treat fluid retention in adults and children with heart failure, liver disease,…
Evolocumab reduces cardiovascular events in diabetes without known atherosclerosis
Evolocumab cuts heart events in high-risk diabetes patients
This prespecified subgroup analysis of a phase 3 RCT evaluated evolocumab added to statin therapy in 3655 high-risk patients with type 2 dia…
Adding evolocumab to statins reduced heart attacks and strokes by about 30% in high-risk diabetes patients without known heart disease.
Systematic review suggests modest risk reduction with SGLT2 inhibitors or ARNIs added to standard therapy in severe heart failure
Moderate evidence supports adding SGLT2 inhibitors to heart failure treatment
This systematic review and network meta-analysis evaluated adding SGLT2 inhibitors or angiotensin receptor-neprilysin inhibitors to neurohor…
A large analysis suggests adding SGLT2 inhibitors may lower risk of death or hospitalization for heart failure, though caution is advised.